Full Text
PRS27 Cost-Utility Analysis of Omalizumab Compared with Standard Therapy in Patients Over Twelve Years Old with Severe Asthma from the Colombian Health System Perspective

Abstract

Authors

J.G. Ariza T. Acosta J.F. Pinzon

Back to Volume 15, Issue 4
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×